Xylogenics is a biotechnology company incorporated in 2008 to provide innovative product solutions utilizing the many benefits of modified yeast microorganisms. Our corporate vision and business objective is to utilize our expertise in engineering yeast to synthesize commercial chemicals from a wide portfolio of renewable environmentally friendly feed stocks. Our first commercial product, known as “SYMMETRRY”, will be launched in 2016 and will produce ethanol more cost effectively in the 200+ starch ethanol production plants in the United States. In addition to pursuing the SYMMETRRY line, we are also pursuing negotiations for services and strategic partnerships with multiple industry leaders.